Continuous positive airway pressure (CPAP) is the preferred treatment for obstructive sleep apnea syndrome because it safely and effectively reduces or eliminates nighttime upper airway obstruction. Unfortunately, CPAP adherence rates are low(30% to 40%). For some patients, a history of trauma contributes to nonadherence by triggering a claustrophobic response to CPAP. Exposure is the treatment of choice for anxiety-based responses, such as claustrophobia. Here, we provide the first demonstration of the successful use of graduated in vivo exposure to treat an individual experiencing a trauma-related claustrophobic response to CPAP.
American Sleep Disorders Association. (1997). International classification of sleep disorders: Diagnostic and coding manual revised. Rochester, MN: Author.
2.
American Thoracic Society. (1994). Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Journal of Respiratory Critical Care Medicine, 150, 1738-1745.
3.
Anthony, M. M.,& Barlow, D. H. (1998). Specific phobia. In V. E. Caballo (Ed.), International handbook of cognitive and behavioural treatments for psychological disorders(pp. 1-22). Elmsford, NY: Pergamon.
4.
Ballester, E., Badia, J. R., Hernandez, L., Carrasco, E., de Pablo, J., & Fornas, C. et al. (1999). Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 159, 495-501.
5.
Berry, R. B. (2000). Improving CPAPcompliance—Manmore than machine. Sleep Medicine, 1, 175-178.
6.
Berry, D. T. R., Webb, W. B., Block, A. J., Bauer, R. M., & Switzer, D. A. (1986). Nocturnal hypoxia and neuropsychological variables. Journal of Clinical Experimental Neuropsychology, 8, 229-238.
7.
Chervin, R. D.,& Guilleminault, C. (1996). Obstructive sleep apnea and related disorders. Neurologic Clinics, 14, 583-609.
8.
Collard, P., Pieters, T., Aubert, G., Delguste, P.,& Rodenstein, D. O. (1997). Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Medicine Reviews, 1, 33-44.
9.
Edinger, J. D., & Radtke, R. A. (1993). Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP. Sleep, 16, 678-680.
10.
Engleman, H. M., Kingshott, R. N., Wraith, P. K., Mackay, T. W., Deary, I. J.,& Douglas, N. J. (1999). Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/ hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 159, 461-467.
11.
Johns, M. W. (1991). A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep, 14, 540-545.
12.
Krieger, J., Kurtz, D., Petiau, C., Sforza, E., & Trautmann, D. (1996). Long-term adherence with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep, 19, S136-S143.
13.
Lavie, P., Here, P., & Hoffstein, V. (2000). Obstructive sleep apnea syndrome as a risk factor for hypertension. British Medical Journal, 320, 479-482.
14.
Likar, L. L., Panciera, T. M., Erickson, A. D., & Rounds, S. (1997). Group education sessions and compliance with nasal CPAP therapy. Chest, 111, 1273-1277.
15.
Marks, I. M. (1973). New approaches to the treatment of obsessive-compulsive disorders. Journal of Nervous & Mental Disease, 156, 420-426.
16.
Marks, I. M., Hodgson, R., & Rachman, S. (1975). Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure: Atwo-year follow-up and issues in treatment. British Journal of Psychiatry, 127, 349-364.
17.
Partinen, M. (1995). Epidemiology of obstructive sleep apnea syndrome. Current Opinions in Pulmonary Medicine, 1, 482-487.
18.
Popescua, G., Lathama, M., Allgarb, V., & Elliotta, M. W. (2001). Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: Usefulness of a 2 week trial to identify factors associated with long term use. Thorax, 5, 727-733.
19.
Rachman, S. (1990). Fear and courage(2nd ed.). New York: Freeman.
20.
Rachman, S., & Taylor, S. (1993). Analyses of claustrophobia. Journal of Anxiety Disorders, 7, 281-291.
21.
Reeves-Hoche, M. K., Meck, R., & Zwillich, C. W. (1994). Nasal CPAP: An objective evaluation of treatment adherence. American Journal of Respiratory and Critical Care Medicine, 149, 149-154.
22.
Rolfe, I., Olson, L. G.,& Saunders, N. A. (1991). Long-term acceptance of continuous positive airways pressure in obstructive sleep apnea. American Review of Respiratory Diseases, 144, 1130-1133.
23.
Sanders, M. H., Gruendl, C. A., & Rogers, R. M. (1986). Patient adherence with nasal CPAP therapy for sleep apnea. Chest, 90, 330-333.
24.
Stoohs, R.,& Guilleminault, C. (1992). Cardiovascular changes associated with obstructive sleep apnea syndrome. Journal of Applied Physiology, 72, 583-589.
25.
U.S. Department of Health and Human Services. (1993). Wake up America: A national sleep alert: Vol. 1 of the report of the National Commission on Sleep Disorders Research. Rockville, MD: Author.
26.
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing in middle-aged adults. New England Journal of Medicine, 328, 1230-1235.
27.
Zozula, R., & Rosen, R. (2001). Compliance with continuous positive airway pressure therapy: Assessing and improving treatment outcomes. Current Opinions in Pulmonary Medicine, 7, 391-398.
